59346-65-5

Basic information

• Product Name: Bromidophosphoric acid di(tert-butyl) ester
• Synonyms: Bromidophosphoric acid di(tert-butyl) ester
• CAS NO: 59346-65-5
• Molecular Formula: C₈H₁₈BrO₃P
• Molecular Weight: 273.1
• Mol File: 59346-65-5.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 247.5±23.0 °C(Predicted)
• Appearance: /
• Density: 1.295±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Bromidophosphoric acid di(tert-butyl) ester(CAS DataBase Reference)
• NIST Chemistry Reference: Bromidophosphoric acid di(tert-butyl) ester(59346-65-5)
• EPA Substance Registry System: Bromidophosphoric acid di(tert-butyl) ester(59346-65-5)

Safety Data

• Hazardous Substances Data: 59346-65-5(Hazardous Substances Data)

Upstream product

• 13086-84-5 di-tert-butyl phosphite 

Downstream Products

• 169565-39-3 di-tert-butyl-4-formyl-2-nitrophenyl phosphate 
• 857896-73-2 phosphoric acid di-tert-butyl 2-formylphenyl ester 
• 169565-43-9 di-tert-butyl-4-(bromomethyl)-2-nitrophenyl phosphate 
• 169565-42-8 di-tert-butyl-4-(chloromethyl)-2-nitrophenyl phosphate 
• 169565-41-7 di-tert-butyl-4-(fluoromethyl)-2-nitrophenyl phosphate 
• 169565-40-6 di-tert-butyl-4-(hydroxymethyl)-2-nitrophenyl phosphate 
• 289051-05-4 phosphoric acid di-tert-butyl ester 2-(2-pentylsulfanyl-acetylamino)-2-phenyl-ethyl ester 
• 857896-74-3 phosphoric acid di-tert-butyl 2-hydroxymethylphenyl ester 
• 917480-07-0 {2-[4-(di-tert-butoxy-phosphoryloxy)-3-formyl-phenyl]-2-hydroxy-ethyl}-[6-(4-phenyl-butoxy)-hexyl]-carbamic acid tert-butyl ester 
• 1056135-43-3 {2-[4-(di-tert-butoxyphosphoryloxy)-3-formylphenyl]-2-oxoethyl}-[6-(4-phenylbutoxy)hexyl]carbamic acid tert-butyl ester 

Relevant articles and documents

-

-

BENZYLPHOSPHATE AND SUBSTITUTED BENZYLPHOSPHATE PRODRUGS FOR TRE TREATMENT OF PULMONARY INFLAMMATION

A prodrug of a corticosteroid, lidocaine or related local anesthetic composition for formulation for delivery by aerosolization to inhibit inflammation in asthmatic lungs is described. The prodrug is preferably formulated in a 5 ml solution of a quarter normal saline having pH between 5.0 and 7.0 for the treatment of respiratory tract inflammation by an aerosol having mass medium average diameter predominantly between 1 to 5 μ produced by nebulization or dry powder inhaler.